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Stefan Eick*, Brandon Loudermilk, Erik Walberg and Moritz N WenteAbstract
Background: In 1998, an electrothermal bipolar vessel sealing (EBVS) system was introduced and quickly became an
integral component of the surgical armamentarium in various surgical specialties. Currently available EBVS instruments
use a scissor-like jaw configuration and closing mechanism, which causes decreasing compression pressure from the
proximal to the distal end of the jaws. A new EBVS system is described here which utilizes a different instrument
jaw configuration and closing mechanism to enable a more homogeneous pressure distribution despite longer
instrument jaws.
Methods: Results of jaw pressure distribution measurements as well as sealing experiments with subsequent burst
pressure measurements ex vivo on bovine uterine arteries are demonstrated. Furthermore, an in vivo evaluation of the
new EBVS system in a canine and porcine model including histological examination is presented.
Results: The device revealed an even pressure distribution throughout the whole jaw length. The ex vivo burst
pressure measurements revealed high average burst pressures, above 300 mmHg, independent of the outer diameter
(1 to 7 mm) of the tested vessels. Histological evaluation of sealed vessels 21 days postoperatively demonstrated sealed
and fused vessels without adjacent tissue damage.
Conclusions: The even pressure distribution leading to a sufficient tissue sealing in combination with the novel closing
mechanism and extended jaw length differentiates the novel device from other available EBVS systems. This might
offer a reduction of the overall procedure time, which should be further evaluated in a clinical study.
Keywords: Surgical instruments, Tissue sealing, Laparoscopic surgery, Hemostasis, Electrocoagulation, Electrosurgery,
Thermal injury, Burst pressure, Equipment designBackground
Since the introduction of an electrothermal bipolar
vessel sealing (EBVS) system in 1998 and initial reports
of its clinical usage, this technology has evolved to a
standard method for sealing and transecting blood vessels
[1,2]. Today, EBVS systems are offered by various man-
ufacturers and widely used in several surgical specialties
such as general and visceral surgery [1,3,4], gynecology
[5,6], urology [2,7], cardio-thoracic [8], and pediatric
surgery [7,9]. Recent systematic reviews and meta-analyses
of randomized controlled clinical trials [10-12] revealed* Correspondence: stefan.eick@aesculap.de
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reproduction in any medium, provided the orthat EBVS systems are safe and at least equally effective
concerning blood loss and operating time in comparison
to ultrasonic energy devices for blood vessel transection in
abdominal surgery.
Besides providing electrothermal energy via a feedback-
controlled electrosurgical process, it is equally important
for good seal stability and reliable sealing quality to apply
sufficient mechanical force to the tissue, as already pointed
out in early research articles [13]. Therefore, exact con-
trolling of the compressive force within the instrument is
considered as highly important and a well-defined and
homogeneous tissue compression throughout the whole
length of the instrument jaws is desirable [14,15].. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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jaw configuration and closing mechanism, which causes
decreasing compression pressure from the proximal to the
distal end of the jaws. Thus, a possible weakness in the
sealing quality can be found at the tip of the instrument,
especially when the jaws are completely filled with tissue
during the sealing process. The longer the jaws of such a
scissor-like instrument are, the more pronounced is this
effect. This especially limits the maximum length of the
jaws and the sealing electrodes of scissor-like laparoscopic
instruments with a diameter of 5 mm.
Because of these effects of uneven pressure distribution
and limited electrode length as well as manufacturers
focus in the development of the sealing process on speed,
surgeons might be accustomed to employing multiple
energy activation cycles to seal bigger arteries for a
higher confidence in the seal stability. Consecutive
sealing procedures next to each other or even at the
same position before activating the cutting mechanism
of the device is called “double seal” or “overlapping seal”;
however, this has only been published rarely in the
scientific literature and can sometimes only be evaluated
in published videos [16-18].
The aim of the given article is to report on a new
EBVS system with focus on a 5 mm laparoscopic vessel
sealing instrument, which utilizes a different instrument
jaw configuration and closing mechanism to enable a
more homogeneous pressure distribution despite longer
instrument jaws in comparison to other known vessel
sealing instruments. In detail, the jaw configuration and
results of jaw pressure distribution measurements as well
as sealing experiments with subsequent burst pressure
measurements ex vivo on bovine uterine arteries are
demonstrated. Finally, an in vivo evaluation of the new
EBVS system in a canine and porcine model including
histological examination is presented.
Methods
Vessel sealing system
The new EBVS system evaluated in this study is a bipolar
electrosurgical system and consists of the Lektrafuse RF
generator and the laparoscopic Caiman® 5 instrument
(Aesculap AG, Tuttlingen, Germany). The RF Generator is
capable of delivering an AC power of 150 W in an imped-
ance range between 10 and 90 Ohms. The instrument-
specific feedback-controlled sealing algorithm is primarily
optimized for seal quality and safety and is automatically
selected, when the instrument is attached to the generator.
The Caiman® 5 is a 5 mm laparoscopic vessel sealing
instrument with a shaft length of 36 cm, 360° shaft rotation
and a pistol type handle (Figure 1). The instrument
jaws carry an upper and a lower sealing electrode. In
combination with the Lektrafuse RF generator it can be
used to seal blood vessels of up to and including 7 mmdiameter and tissue bundles as will fit into the jaws.
The sealed blood vessel or tissue can subsequently be
divided by an included hand-controlled mechanical
blade. The instruments used for all experiments and
figures in this publication were prototypes of the first
generation of Caiman® 5 instruments, which were exclu-
sively available in the United States.
Instrument jaws and closing mechanism
The major novel development in the evaluated EBVS
system for a reliable, excellent seal quality is a special
hinged jaw design of the instrument. To ensure even
pressure distribution and tissue compression in the
instrument jaws, an additional hinge at approximately
half of the length of the lower jaw is included (Figure 2).
The distal pivoting component of the lower jaw, which
contains a sealing electrode, is attached at its pivot
point to the proximal portion of the lower jaw. The
proximal portion of the lower jaw then holds the upper
jaw which is fixed to the shaft of the instrument. Thus,
the electrode-containing distal portion of the lower jaw
is tiltable in relation to the shaft of the instrument as
well as to the upper jaw and electrode. A spring is
included in the lower jaw assembly, which biases the
distal tip towards the upper jaw (Figure 2A). Thus, unlike
conventional scissor-like vessel sealing devices, the
instrument jaws close first at the distal tip of the instru-
ment (Figure 2B). When further closing the instrument
jaws, the movable front part of the lower jaw is able to tilt
in relation to the upper jaw in a way that both electrodes
are finally aligned in parallel (Figure 2C).
This closing mechanism should avoid that any tissue is
being pushed out of the jaws during closing, and enables
a parallel jaw alignment with varying thickness of tissue
and thus an even pressure distribution and tissue com-
pression within the jaws. In the final configuration, the
user enables the sealing process by pushing the activation
button one time and the vessels and/or connective tissues
are sealed and finally cut mechanically by the surgeon.
Due to the closing mechanism and the even tissue
compression throughout the whole length of the instru-
ment jaws, the jaws and the sealing electrodes can be
longer than in other 5 mm laparoscopic vessel sealing
instruments with scissor-like jaws, resulting in a superior
sealing length of 26,5 mm.
Bench testing
Jaw pressure measurements
To measure the distribution and amount of pressure
within the jaws of the Caiman® 5 instrument, a pressure
measurement system (Tekscan, Inc., South Boston, MA,
USA) was utilized. For comparison, the jaw pressure was
also measured for two conventional vessel sealing instru-
ments: the Covidien LigaSure™ 5 mm and the Covidien
Figure 1 Caiman® 5 vessel sealing instrument in a side view.
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Boulder, CO). All measurements were made with the
same measurement setup and measurement procedure
described in this section.
The pressure measurement system consist of a Tekscan
5027 Sensor, which is clamped into the EH-2 Tekscan
handle and connected to a personal computer with I-
Scan® lite software. The sensor and measurement system
were calibrated for two points within the range of force
expected (roughly 1.1 MPa) and equilibrated for the study
per standard operation procedure and according to manu-
facturer‘s recommendation.
To simulate the tissue layers, which are compressed
within the instrument jaws, a piece (roughly 4 cm by
4 cm) of a 0.5 mm thick compressible silicone pad (50A
durometer silicone rubber pad #3788 T21; McMaster-
Carr®, Elmhurst, IL) was placed on either side of the
pressure sensor. To ensure an accurate force reading, the
silicone was placed even with or just inside of the sensors
footprint where the jaws are clamped onto the sensor. The
sensor with the silicone pads was fully inserted into
the jaws of the instrument and the jaw set was closed.Figure 2 Schematic side view of the Caiman® 5 hinged jaws
closing mechanism. Jaws open (A), closed at the tip (B), and
completely closed (C).The sensor reading was stabilized for approximately two
seconds and recorded.
Burst pressure measurements
To evaluate the initial sealing quality and reliability of
the EBVS system, burst pressure measurements on sealed
explanted arteries of various diameters were utilized. The
standardized burst pressure measurements were conducted
with a laboratory burst pressure measurement system based
on a digital gear pump (pump head model #07002-25; gear
pump drive model #75211-30; Cole-Parmer, Court Vernon
Hills, IL, USA;) as described in the following: the untreated
bovine uterine arteries, sized approximately 1 to 7 mm
in outer diameter (OD), were freshly frozen directly
after harvesting. Before the experiments, the frozen tissue
was allowed to thaw to approximately room temperature,
bagged and placed in warm water until it had reached
approximately 37°C. Testing was performed with tissue
temperatures between 25°C (room temperature) and 37°C
(body temperature).
Three different size classes of arteries were defined
according to their OD when laying approximately flat
across a finger: small (1–2 mm), medium (2–4 mm),
and large (4–7 mm). The tissue samples were inspected
to locate an artery with an OD in the desired size range
for sealing and also inspected to assure that the vessels
were not cut or damaged in any way. If the artery was
encapsulated in connective tissue it was not separated
from the tissue.
After confirming the tissue was moist, the artery was
clamped with the Caiman® 5 instrument and the sealing
was performed by activating the Lektrafuse RF generator
once. After completion of the sealing, the arteries were
divided using the cutting mechanism on the instrument.
Then, the non-sealed end of each artery was slipped on
to the appropriate sized dispensing needle attached to
the vessel burst pressure measurement system and the
artery was secured mechanically onto the needle with
hemostats with conformal tubing on each jaw to assure
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5 mm between the seal and the needle.
Burst pressure measurement was started by pumping
water into the artery with a flow rate of 15 or 47 ml/min
depending on needle diameter. If any leaks were observed
along the needle/artery attachment or anywhere along
the artery (other than at the sealed end), those leaks
were clamped. The maximum pressure was recorded
once the artery wall leaked or the sealed end burst.
Arteries that were damaged during test set up were not
further evaluated.
There is no clear standard given in the literature for a
required burst pressure measurement for separating a
successful artery seal from a failure. Published values
strongly vary from 50 mmHg [19], 150 mmHg [8],
250 mmHg [14], 300 mmHg [20-22], 360 mmHg [23],
up to 400 mmHg [24]. Nevertheless, burst pressure
provides a reproducible stability index of the seal. We
chose 300 mmHg or 2.5 times of the average systolic
artery pressure as requirement for a successful seal,
suggesting this will be safe under systolic pressure in
normal patients or those with treated hypertension.
Animal test
Animal tests with blood vessel sealing were performed
to prove the sufficiency of the vessel sealing system’s
capabilities in vivo as well as to evaluate acute and
chronic survival of the animals. Furthermore, the sealed
tissues were evaluated macroscopically and histologically.
The animal studies were designed as regulatory study
required by the FDA for device clearance and were
performed at BioSurg, Inc. animal facility (Winters,
CA, USA). BioSurg is a certified Class R Research
Facility under the Animal Welfare Act (7 U.S.C. 2131
et seq., Certificate No. 93-R-0200, Customer No. 1139) and
maintains an Animal Welfare Assurance (No. A3751-01)
by the Office of Laboratory Animal Welfare (OLAW)
that was submitted in compliance with the Public
Health Service (PHS) Policy on Humane Care and Use
of Laboratory Animals. The Institutional Animal Care
and Use Committee (IACUC) reviewed and approved
all activities involving the use of live "covered" animals
within this study prior to their initiation (Protocol No.
SA0908n).
Overall, the experiments were performed on three
dogs and one pig. The Caiman® 5 was used to seal and
divide mesenteric and parametrial tissues and structures
surrounding the targeted organs. For every transaction site,
the seal process was only activated once. To demonstrate
substantial equivalence, another dog was operated on
using the predicate, conventional EBVS system (LigaSure™
5 mm instrument and ForceTriad™ Energy Platform,
Covidien). The animals were examined acutely for vessel
sealing and were then survived chronically for 21 days.Each animal was positioned in dorsal recumbency, anes-
thetized and surgically prepped and draped according
to BioSurg’s standard operating procedures. A BioSurg
Veterinary surgeon performed the operative procedures
using sterile technique throughout all procedures.
In the three dogs, various surgical procedures including
left nephrectomy, ovariohysterectomy and splenectomy
were performed with the Caiman® 5. In the comparative
dog, a splenectomy and nephrectomy were performed
with the conventional EBVS system. In the pig, the left
carotid artery was transected using the Caiman® 5. Several
treated vascular segments were removed acutely and
preserved in 10% Neutral Buffered Formalin (NBF) for
histologic analysis at a later date. After the sealed tissues
had been examined for adequate hemostasis, the abdomen
was closed and each animal recovered as per BioSurg’s
anesthesia and surgical SOPs. The animals were survived
post operatively for a period of 21 days.
Histology/pathology
After 21 days, the animals were sacrificed and a necropsy
was performed on each animal with emphasis on iden-
tifying the treatment sites. During necropsy, evidence
of mechanical or thermal injury to adjacent tissue struc-
tures and recent or active bleeding from treatment sites
was assessed. Chronic treatment sites were photographed,
excised en bloc, and immersion fixed in 10% NBF. All
transected vascular segments (acute and chronic) were
trimmed and routinely processed for histopathologic
processing and microscopic analysis. Briefly, tissues
were dehydrated in a series of graded alcohol solutions,
cleared in xylene, embedded in paraffin, sectioned at
4–6 microns, and stained with hematoxylin and eosin
(H&E) for light microscopic evaluation. Acute and chronic
histology were compared to assess efficacy/safety concerns
that could be related to vessel leakage at the occlusion
site due to thermal injury and possible tissue necrosis.
Results
Bench testing
Jaw pressure distribution measurement
The results of jaw pressure measurements of the Caiman®
5 instrument with the hinged jaw design and two conven-
tional vessel sealing instruments with scissor-like jaws are
shown in Figure 3.
While the hinged jaw of the Caiman® 5 enables an even
pressure distribution in a range between roughly 0.6
and 1.2 MPa throughout the whole jaw length with
only a slight medial maximum, the other two sealing
devices show an uneven pressure distribution. The pressure
strongly decreases from more than 1.4 MPa at the proximal
jaw end to virtually zero at the distal tip and within the
last quarter of the jaw length. Figure 3 also shows the jaws
and the sealing electrodes of the Caiman® 5 are longer in
Figure 3 Jaw length and compression pressure distribution. The compression within the jaws of the Caiman® 5 sealing device in comparison
to other electrosurgical sealing devices with scissor-closing jaws is shown. For the conventional devices, the pressure decreases from the proximal
end of the jaws to the distal tip, reaching a pressure of virtually zero within the last quarter of the jaw length. The hinged jaw of the new device
enables much more even pressure distribution throughout the jaw length of 26,5 mm. Pressure data outside of the jaw footprint (dashed line)
was removed for clarity.
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sealing devices.Burst pressure measurements
Table 1 summarizes the results of 272 ex vivo burst pres-
sure measurements done with the Caiman® 5 instruments
on unfrozen bovine uterine arteries with outer diameters
between 1 and 7 mm. As a requirement for a successful
seal, a minimum burst pressure of 300 mmHg, 2.5 times
standard systolic arterial blood pressure, was chosen.
For all three size classes of arteries (OD small, OD
medium, and OD large), the burst pressure measurements
showed high average burst pressures of roughly 3 times the
minimum requirement. Out of all 272 measurements, only
for one artery (size OD small, burst pressure 131 mmHg),
the minimum burst pressure was not reached.Animal test
Altogether, 70 blood vessel and tissue seals, including 38
arteries with outer diameters between 1 and 8 mm (3.0 ±
2.3 mm; mean ± SD) and 28 non-arterial vessels with outerTable 1 Burst pressure measurements
OD small (n = 85)
OD (mm) BP (mmHg) OD (m
Mean ± SD 1.9 ± 0.3 1015 ± 536 3.3 ± 0
Min / max 1.0 / 2.0 131 / 2975 2.0 / 4
BP < 300 (n) 1 0
Results of burst pressure (BP) measurements for arteries with varying outer diamete
(SD), minimum, and maximum values are shown. OD small: 1–2 mm, OD medium: 2diameters between 1 and 10 mm (3.0 ± 2.5 mm), were
performed within the three dogs and one pig. Each site
was transected with a single activation of the sealing
process and subsequent cutting.
For all 70 seals, no acute seal failure was observed.
The average seal duration was 3.9 ± 1.1 s (min: 1.8 s, max:
6.4 s). The average measured thermal spread beyond
the instrument jaws was less than 1 mm. No arcing and
charring and only minor tissue adhesion occurred. All
four animals survived for 21 days with no postoperative
complications and acceptable animal stress. After 21 days,
the reoperation (necropsy) was performed, showing no
chronic seal failures and no mechanical or thermal injury
in the treatment sites for all animals.Histology/pathology
Canine model
All acutely collected arteries of the three dogs demon-
strated similar histopathologic changes. The transected
ends of the arteries revealed fresh coagulative thermal
necrosis and appeared sealed and fused. In the moreOD medium (n = 92) OD large (n = 95)
m) BP (mmHg) OD (mm) BP (mmHg)
.6 1017 ± 514 5.2 ± 0.9 865 ± 389
.0 304 / 2428 4.0 / 7.0 313 / 2288
0
rs (OD) between 1 and 7 mm. For all values, the mean, standard deviation
–4 mm, OD large: 4–7 mm.
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intimal layer was noted. There was no further adjacent
tissue damage. As representative examples, Figure 4 shows
photomicrographs of H&E stained acute sections through
a renal (A) and a splenic (B) artery.
After 21 days, gross assessment showed healed treat-
ment sites with no indication of recent or active bleeding
and of adjacent tissue or organ damage. Microscopically,
the treated arterial segments all demonstrated occlusive
thrombosis at the transected ends with a surrounding cap
of organized fibrotic tissue. The luminal thrombus was
typically organized with sprouting of endothelial cells and
fibroblasts forming interconnected microvascular channels
and focally lympho-histiocytic inflammatory cells. Figure 4
(C,D) shows representative photomicrographs of H&E
sections stained in “chronic stage” as examples.A
C
Figure 4 Histological evaluation of arteries sealed with the Caiman® 5
(A, B) and chronic phase (C, D) after sealing with the Caiman® 5 instrumen
For both chronic arteries, the black arrow demonstrates the transected end
The tissue appears fused and sealed. C: The black arrow demarcates the dis
There is an occlusive, organized luminal thrombus, and the distal end of th
fibers dissects into the surrounding fat. D: The black arrow indicates the oc
is surrounded by a fibrous cap.The remaining transected ends of the arteries demon-
strated both coagulative thermal necrosis (a result of the
initial treatment) and lytic necrotic change (a result of
the subsequent inflammatory process). The surrounding
fibrous cap was minimally inflamed with lymphocytes
and histiocytic cells. Xanthogranulomatous changes, often
with scant mineralized centers, were also scattered in the
vicinity in the surrounding adherent fat and nerve bundles.
All acute and chronic histopathologic tissue changes
were similar to those found in the comparative fourth
dog, which was operated on with the conventional blood
vessel sealing system.
Porcine model
The transection site of the carotid artery was identified
grossly and was surrounded by fibrous adhesion. ThereB
D
instrument. Photomicrographs of H&E stained sections in acute
t. Serial sections through renal (A, C) and splenic (B, D) arteries. A, B:
of the artery, which is characterized by coagulative thermal necrosis.
tal end of the transected segment surrounded by a cap of fibroplasia.
e artery is suffused with hemorrhage; a modest amount of fibrous
clusive organized luminal thrombus. The transected end of the artery
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and distal sections of the carotid artery were evaluated
microscopically.
Similar to the canine samples, there was an occlusive
luminal thrombus in both segments, which was organized
by fibroblasts and contained pockets of fibrin or blood.
Organized fibrovascular tissue capped both the proximal
and distal ends. A minimal degree of lymphohistiocytic
inflammation was present throughout.
Discussion
Strongly driven by the increasing percentage of minimally
invasive surgical procedures, more advanced electrosurgical
instruments with the ability to transect tissues and seal
vessels became a standard in various fields of surgery,
since their introduction just more than a decade ago. The
instruments undergo a steady development, as surgeons
demand them for more and more complex procedures,
such as liver and pancreatic resections [25,26].
In particular an increased jaw length with equally dis-
tributed closing pressures and a safe closing mechanism
starting at the tip of the device were the demands when
the development of the new device started. Due to the
laws of mechanics, every scissor-like instrument produces
an uneven pressure distribution between the jaws when
grasping tissue. The uneven pressure distribution is more
pronounced as the tissue thickness between the jaws is
increased. For blood vessel sealing instruments, it is
well known that sealing process and sealing quality
strongly depend on the pressure [14,15]. Therefore,
every scissor-like sealing instrument produces uneven
sealing quality due to strong pressure variations from
the proximal to the distal end of the jaws. Especially at
the tip of the instrument, a satisfactory sealing quality
cannot be guaranteed, when the jaw of the instrument
is completely filled with tissue. Due to the hinged jaw, the
Caiman® 5 instrument shows an even pressure distribution
with only a slight maximum at the middle of the jaw
length, as could be shown with pressure measurements in
the instrument jaws.
Because of the even pressure distribution in hinged jaws,
it was possible to construct the Caiman® 5 instrument with
long jaws with 26,5 mm of sealing length, which is one
third longer than other available vessel sealing instruments
on the market. This allows the sealing of more tissue with
one bite than with other instruments. In combination with
an optimized sealing process, the instrument allows for
constant sealing quality throughout the whole length of
the instrument jaws with a single activation of the sealing
process, as was shown with successful sealing experiments
both ex vivo and in vivo.
On explanted bovine arteries, the burst pressure mea-
surements showed reliable sealing results with average
burst pressures of roughly three times the minimumrequirement for all three evaluated size classes of arteries.
Those results are in the same range or even better than
reported values in the literature [8,14,15,19-24] and
demonstrate the reproducibility of a high initial stability of
artery seals with the new EBVS system using the Caiman®
5 instrument.
In a canine and a porcine animal model, the acute and
chronic stability and healing of artery seals with the novel
instrument was evaluated and compared to seals with a
conventional system in vivo. The gross and histological
findings were similar in all animals at each site. There was
no evidence of recent or active bleeding at any of the
transection sites, including the left carotid artery in the
porcine animal model, showing reliability of the Caiman®
5 instrument even for sealing of large blood vessels.Conclusions
Quality and reliability of blood vessel sealing strongly
depends on the pressure in the instrument’s jaws. Scissor-
like instruments show strong pressure variations from
the proximal to the distal end of the jaws, potentially
leading to uneven sealing quality with possible weaknesses
at the tip of the instrument. Utilizing an additional hinge
in the lower instrument jaw, the Caiman® 5 instrument
establishes an even pressure distribution within the instru-
ment’s jaws, which are longer than other 5 mm laparo-
scopic blood vessel sealing instruments’ jaws. As shown
ex vivo and in vivo, the system enables acute seal stability
with a single process activation and chronic healing of
blood vessel transaction sites. The evaluated EBVS system
offers a constant level of confidence in seal quality (safe
hemostasis with one seal) in the tested setup and, in
combination with the longer instrument jaws, the pro-
spective of a reduced overall procedure duration, which
should be evaluated in a clinical trial.
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